SCIENTECH (02291) News

Share Repurchases on September 15 | Tencent, HSBC Holdings, and others conducted share buybacks, with Tencent spending HK$101 million.

According to documents disclosed by the Hong Kong Exchange on September 16,$Tencent (00700.HK)$、$HSBC Holdings (00005.HK)$Pending share repurchase.① $Tencent (00700.HK)$On September 15, the company

Futu News09:30

Xintai Medical (02291) repurchased 47,000 shares for HK$519,200 on September 15.

Xintai Medical (02291) announced that on September 15, 2026, the company repurchased 47,000 shares at a total cost of HK$519,200, with repurchase prices ranging from HK$10.95 to HK$11.20 per share.

Zhitong FinanceSep 15 18:28

September 14 Buyback Roundup | Tencent and HSBC Holdings, among others, conducted share buybacks, with Tencent spending HK$100 million.

According to documents disclosed by the Hong Kong Exchange on September 15,$Tencent (00700.HK)$、$HSBC Holdings (00005.HK)$Pending share repurchase.① $Tencent (00700.HK)$On September 14, the company

Futu NewsSep 15 09:30

Xintai Medical (02291) repurchased 48,000 shares at a total cost of HK$515,900 on September 14.

Xintai Medical (02291) announced that on September 14, 2026, the company repurchased 48,000 shares at a total cost of HK$515,900, with repurchase prices ranging from HK$10.12 to HK$10.99 per share.

Zhitong FinanceSep 14 18:37

September 11 Buyback Roundup | Tencent, Baidu Group-W, and others conduct share buybacks, with Tencent spending HK$100 million

According to documents disclosed by the Hong Kong Exchange on September 14,$Tencent (00700.HK)$、$Baidu Group-W(09888.HK)$Pending share repurchase.① $Tencent (00700.HK)$On September 11, the company

Futu NewsSep 14 09:40

On September 11, Xintai Medical (02291.HK) repurchased 110,000 shares at a cost of HK$1.19 million.

Gelonghui, September 11 | Xintai Medical (02291.HK) announced that it repurchased 110,000 shares on September 11 at a total cost of HK$1.19 million, with a repurchase price per share ranging from HK$10.49 to HK$11.50.

Gelonghui FinanceSep 11 18:30

September 10 Buyback Roundup | Tencent and 3SBio, among others, conducted share buybacks, with Tencent spending HK$100 million

According to disclosure documents released by the Hong Kong Exchange on September 11, $Tencent(00700.HK)$ and $3SBio(01530.HK)$ repurchased shares. ① On September 10, $Tencent(00700.HK)$ repurchased 235,000 ordinary shares, involving an amount of HK$100 million, with the repurchase price per share ranging from HK$425.2 to HK$430.2. Since the resolution on the buyback mandate was passed, the cumulative number of securities repurchased stands at 44.8487 million shares, representing 0.49187% of the number of issued shares at the time the ordinary resolution was passed. ② $3SBio(01530.

Futu NewsSep 11 09:40

Xintai Medical (02291) repurchased 96,000 shares for HK$1.088 million on September 10.

Xintai Medical (02291) announced that it repurchased 96,000 shares for HK$1.088 million on September 10, 2026.

Zhitong FinanceSep 10 18:46

September 9 Buyback Roundup | Tencent, HSBC Holdings, and others conduct share buybacks, with Tencent spending HK$100 million

According to disclosure documents filed with the Hong Kong Exchange on September 10, companies including $Tencent (00700.HK)$ and $HSBC Holdings (00005.HK)$ repurchased shares. ① $Tencent (00700.HK)$ repurchased 231,000 ordinary shares on September 9, involving a total amount of HK$100 million, with repurchase prices ranging from HK$438.2 to HK$432.8 per share. Since the resolution authorizing share repurchases was passed, the cumulative number of securities repurchased stands at 44.6137 million shares, representing 0.48929% of the issued shares outstanding at the time the ordinary resolution was approved. ② $HSBC Holdings (00005.HK)$

Futu NewsSep 10 09:20

Xintai Medical (02291.HK) repurchased 55,000 shares on September 9 at a cost of HK$599,000.

Gelonghui, September 9 | Xintai Medical (02291.HK) announced that on September 9, it repurchased 55,000 shares at a total cost of HK$599,000, with a repurchase price per share ranging from HK$10.3 to HK$11.27.

Gelonghui FinanceSep 9 18:26

Share Buyback Roundup on September 8 | Tencent, Xiaomi Group-W, and others conducted share buybacks, with Tencent spending HKD 100 million

According to documents disclosed by the Hong Kong Exchange on September 9, companies including $Tencent (00700.HK)$ and $Xiaomi Group-W (01810.HK)$ have repurchased shares. ① $Tencent (00700.HK)$ repurchased 230,000 ordinary shares on September 8, involving an amount of HK$100 million, with a repurchase price per share ranging from HK$435.2 to HK$439.6. Since the resolution on the repurchase mandate was passed, the cumulative number of securities repurchased is 44.3827 million shares, accounting for 0.48676% of the number of issued shares at the time the ordinary resolution was passed. ② $Xiaomi Group-W (01810.

Futu NewsSep 9 09:30

Xintai Medical (02291.HK) repurchased 175,000 shares on September 8, at a cost of HK$2.0279 million.

Gelonghui, September 8 | Xintai Medical (02291.HK) announced that on September 8, it repurchased 175,000 shares at a total cost of HK$2.0279 million, with a repurchase price per share ranging from HK$11 to HK$12.25.

Gelonghui FinanceSep 8 18:54

Xintai Medical (02291) repurchased 175,000 shares for HK$2.0279 million on September 8.

Xintai Medical (02291) announced that it repurchased 175,000 shares for HKD 2.0279 million on September 8, 2026.

Zhitong FinanceSep 8 18:53

Share Buyback Roundup on September 7 | Bilibili-W, Tencent, and others conducted buybacks, with Bilibili-W spending HKD 784 million.

According to disclosures filed with the Hong Kong Exchange on September 8, companies including Bilibili-W (09626.HK) and Tencent (00700.HK) repurchased shares. ① On September 4, Bilibili-W (09626.HK) repurchased 6.7955 million Class B shares (shares with different voting rights), involving a total amount of HKD 784 million, with a repurchase price per share ranging from HKD 115.38 to HKD 115.38. ② On September 7, Tencent (00700.HK) repurchased 228,000 ordinary shares, involving a total amount of HKD 100 million, with a repurchase price per share ranging from HKD 442.4 to HKD 4

Futu NewsSep 8 09:30

On September 7, XinTai Medical (02291.HK) repurchased 175,000 shares at a cost of HK$2.215 million.

Gelong Hui, September 7 | Xintai Medical (02291.HK) announced that on September 7, it repurchased 175,000 shares at a cost of HKD 2.215 million, with a repurchase price per share ranging from HKD 12.2 to HKD 13.1.

Gelonghui FinanceSep 7 18:59

Hong Kong Stocks in Focus | Xintai Medical (02291) Falls Nearly 6% After Being Removed from Stock Connect; Company Reports Decline in H1 Revenue and Net Profit

Xintai Medical (02291) traded with downward volatility today. As of press time, the stock had fallen 5.94% to HK$12.50, with a turnover of HK$7.031 million.

Zhitong FinanceSep 7 14:13

Share Buybacks on September 4 | Companies including Tencent and HSBC Holdings engaged in share repurchases, with Tencent spending HKD 100 million.

According to documents disclosed by the Hong Kong Exchange on September 7, companies such as $Tencent (00700.HK)$ and $HSBC Holdings (00005.HK)$ repurchased shares. ① $Tencent (00700.HK)$ repurchased 226,000 ordinary shares on September 4, involving an amount of HK$100 million, with a per-share repurchase price ranging from HK$447.4 to HK$440.2. Since the resolution on the share repurchase mandate was passed, the cumulative number of securities repurchased stands at 43.9247 million shares, representing 0.48174% of the number of issued shares at the time the ordinary resolution was approved. ② $HSBC Holdings (00005.HK)$

Futu NewsSep 7 09:30

On September 4, Xintai Medical (02291.HK) repurchased 86,000 shares at a cost of HK$1.128 million.

Gelonghui, September 4 | Xintai Medical (02291.HK) announced that on September 4, it repurchased 86,000 shares at a cost of HK$1.128 million, with the repurchase price per share ranging from HK$12.9 to HK$13.4.

Gelonghui FinanceSep 4 20:12

Express News | Baidu and 53 other individual stocks will be included in the list of eligible securities for the Hong Kong Stock Connect under the Shanghai-Hong Kong Stock Connect.

The Shanghai Stock Exchange announced adjustments to the list of eligible stocks for the Southbound Trading under the Shanghai-Hong Kong Stock Connect, adding 54 stocks including Baidu and Ascletis Pharma, and removing 15 stocks including Youjia Innovation.

BreakingsSep 4 19:33

Table: Scientech Corp Aug Rev NT$1.07B Vs NT$904.9M

Scientech Corp. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$1,068,346,000 NT$904,939,000 Jan-Aug

Dow JonesSep 4 16:14